Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9397367 | 0.93 | TSHR (0.34) | TSHRKMT2ACYP2D6GAAHTT | |
| SCHEMBL21163069 | 0.92 | TSHR (0.31) | TSHRKMT2ACYP2D6GAAHTT | |
| SCHEMBL21163060 | 0.91 | GAA (0.40) | GAA | |
| SCHEMBL21163250 | 0.91 | GAA (0.40) | GAA | |
| SCHEMBL21162850 | 0.91 | GAA (0.40) | GAA | |
| SCHEMBL21162852 | 0.91 | GAA (0.40) | GAA | |
| SCHEMBL21163423 | 0.89 | GAA (0.37) | CYP2D6GAAHTT | |
| SCHEMBL21163395 | 0.87 | GAA (0.42) | TSHRKMT2ACYP2D6GAAHTT | |
| SCHEMBL21162877 | 0.86 | GAA (0.43) | TSHRKMT2ACYP2D6GAAHTT | |
| SCHEMBL21162867 | 0.85 | TSHR (0.32) | TSHRKMT2ACYP2D6GAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975305-B2 | Piperidine derivative, liquid crystal composition, and liquid crystal display element | JNC CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20190194542-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |